咨询客服 咨询客服

Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia

Abstract:
Purpose The aim of this study was to verify whether the distribution of a treatment diary by a pharmacist could influence the adherence to oral treatment with imatinib, nilotinib, and dasatinib in patients with chronic myeloid leukaemia. Methods The level of adherence was calculated using the received daily dose/prescribed daily dose ratio and compared between patients who used a diary and those who did not. Results Forty-four (35.8%) of 123 patients with chronic myeloid leukaemia completed the diary: 20 (45.4%) receiving imatinib, 17 (38.6%) receiving nilotinib, and seven (15.9%) receiving dasatinib. Treatment adherence with the diary calculated using received daily dose/prescribed daily dose method was 93.6% (imatinib 94.9%, nilotinib 91.1%, and dasatinib 95.8%). Adherence during the period without a diary was 86.5% (84.9, 87.4, and 90%). Adherence was significantly greater with than without a diary (p\u2009<\u20090.0001). Conclusions The findings of this study that, in the case of chronic diseases, direct pharmacist–patient contact is important in order to maintain high levels of adherence, and a treatment diary is a valid means of doing this. According to these data, it is necessary to support similar patient-oriented programmes in order to ensure high levels of adherence and optimize drug management.
Author Listing: Fiorenzo Santoleri;Ruggero Lasala;Andrea Logreco;Elena Ranucci;Alberto Costantini
Volume: 25
Pages: 1035 - 1041
DOI: 10.1177/1078155218759184
Language: English
Journal: Journal of Oncology Pharmacy Practice

JOURNAL OF ONCOLOGY PHARMACY PRACTICE

J ONCOL PHARM PRACT

影响因子:0.9
是否综述期刊:否
是否OA:否
是否预警:不在预警名单内
发行时间:-
ISSN:1078-1552
发刊频率:-
收录数据库:SCIE/Scopus收录
出版国家/地区:ENGLAND
出版社:SAGE Publications Ltd

期刊介绍

Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines...

《肿瘤学药学实践杂志》是一本同行评审的学术期刊,致力于教育卫生专业人员为癌症患者提供药学护理。它是国际肿瘤药学从业者协会(ISOPP)的官方出版物。发布相关病例报告和共识指南...

年发文量 197
国人发稿量 7
国人发文占比 3.75%
自引率 0.0%
平均录取率 -
平均审稿周期 -
版面费 US$3750
偏重研究方向 Medicine-Oncology
期刊官网 https://journals.sagepub.com/home/opp
投稿链接 https://mc.manuscriptcentral.com/jopp

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
88.83% 7.67% 0.00% 1.11%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

时间 预警情况
2025年03月发布的2025版 不在预警名单中
2024年02月发布的2024版 不在预警名单中
2023年01月发布的2023版 不在预警名单中
2021年12月发布的2021版 不在预警名单中
2020年12月发布的2020版 不在预警名单中

JCR分区 WOS分区等级:Q4区

版本 按学科 分区
WOS期刊SCI分区
(2021-2022年最新版)
ONCOLOGY Q4
PHARMACOLOGY & PHARMACY Q4

中科院分区

版本 大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY
肿瘤学
4区
PHARMACOLOGY & PHARMACY
药学
4区
2021年12月
基础版
医学
4区
ONCOLOGY
肿瘤学
4区
PHARMACOLOGY & PHARMACY
药学
4区
2021年12月
升级版
医学
4区
ONCOLOGY
肿瘤学
4区
PHARMACOLOGY & PHARMACY
药学
4区
2020年12月
旧的升级版
医学
4区
ONCOLOGY
肿瘤学
4区
PHARMACOLOGY & PHARMACY
药学
4区
2022年12月
最新升级版
医学
4区
ONCOLOGY
肿瘤学
4区
PHARMACOLOGY & PHARMACY
药学
4区